- Hem
- Om universitetet
- Hitta person
- Lisa Nilsson
Lisa Nilsson
Forskningsingenjör
Avd för kirurgi-
Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical
models
Zhi Jie Li, Bo He, Alice Domenichini, Jiulia Satiaputra, Kira H. Wood, Devina D. Lakhiani, Abate A. Bashaw, Lisa M Nilsson, Ji Li, Edward R. Bastow, Anna Johansson-Percival, Elena Denisenko, Alistair R.R. Forrest, Suraj Sakaram, Rafael Carretero, Günter J. Hämmerling, Jonas A Nilsson, Gabriel Y.F. Lee, Ruth Ganss
The Journal of clinical investigation - 2024 -
Insulin Sensitivity Controls Activity of Pathogenic CD4+T Cells in Rheumatoid
Arthritis
Malin Erlandsson, Eric Malmhäll-Bah, Venkataragavan Chandrasekaran, Karin Andersson, Lisa M Nilsson, Sofia Töyrä Silfverswärd, Rille Pullerits, Maria Bokarewa
CELLS - 2024 -
Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma
metastase
Joakim Karlsson, Vasu R. Sah, Roger Olofsson Bagge, Irina Kuznetsova, Munir Iqba, Samuel Alsén, Sofia Stenqvist, Alka Saxena, Lars Ny, Lisa M Nilsson, Jonas A Nilsson
ELIFE - 2024 -
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion
Dogs
Elin Forsberg, Rebecca E Riise, S. Saellstrom, Joakim Karlsson, Samuel Alsén, Valentina Bucher, A. E. Hemminki, Roger Olofsson Bagge, Lars Ny, Lisa M Nilsson, H. Ronnberg, Jonas A Nilsson
Cancers - 2023 -
Genetics and Therapeutic Responses to Tumor-infiltrating Lymphocyte Therapy of Pancreatic Cancer Patient-derived Xenograft
Models
Caroline Vilhav, Lisa M Nilsson, Joakim Karlsson, Johan Bourghardt Fagman, Daniel Giglio, Cecilia Engström, Peter Naredi, Jonas A Nilsson
HPB - 2023 -
A Fraction of CD8+T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T
Cells
Frank Liang, Lisa M Nilsson, Fabian Byvald, Azar Rezapour, Helena Taflin, Jonas A Nilsson, Ulf Yrlid
Cancers - 2022 -
Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant
melanoma
Vasu R. Sah, Joakim Karlsson, Henrik Jespersen, Mattias F Lindberg, Lisa M Nilsson, Lars Ny, Jonas A Nilsson
Melanoma Research - 2022 -
Genetics and Therapeutic Responses to Tumor-Infiltrating
Lymphocyte Therapy of Pancreatic Cancer Patient-Derived
Xenograft
Models
Lisa M Nilsson, Caroline Vilhav, Joakim Karlsson, Johan Bourghardt Fagman, Daniel Giglio, Cecilia Engström, Peter Naredi, Jonas A Nilsson
Gastro Hep Advances - 2022 -
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal
melanoma
Lars Ny, Henrik Jespersen, Joakim Karlsson, Samuel Alsén, Stefan Filges, C. All-Eriksson, B. Andersson, A. Carneiro, H. Helgadottir, Max Levin, I. Ljuslinder, Roger Olofsson Bagge, Vasu R. Sah, Ulrika Stierner, Anders Ståhlberg, G. Ullenhag, Lisa M Nilsson, Jonas A Nilsson
Nature Communications - 2021 -
BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant
glioma
Elisa Funck-Brentano, Dzeneta Vizlin-Hodzic, Jonas A Nilsson, Lisa M Nilsson
Epigenetics - 2021 -
The Microenvironment of Small Intestinal Neuroendocrine Tumours Contains Lymphocytes Capable of Recognition and Activation after
Expansion
Tobias Hofving, Frank Liang, Joakim Karlsson, Ulf Yrlid, Jonas A Nilsson, Ola Nilsson, Lisa M Nilsson
Cancers - 2021 -
Small molecule inhibitors and a kinase-dead expressing mouse model demonstrate that the kinase activity of Chk1 is essential for mouse embryos and cancer
cells
Somsundar Veppil Muralidharan, Lisa M Nilsson, Mattias F Lindberg, Jonas A Nilsson
Life Science Alliance - 2020 -
Molecular profiling of driver events in metastatic uveal
melanoma
Joakim Karlsson, Lisa M Nilsson, Suman Mitra, Samuel Alsén, Ganesh V Shelke, Vasu R. Sah, Elin Forsberg, Ulrika Stierner, C. All-Eriksson, Berglind Osk Einarsdottir, Henrik Jespersen, Lars Ny, Per Lindnér, Erik Larsson, Roger Olofsson Bagge, Jonas A Nilsson
Nature Communications - 2020 -
SUMO pathway inhibition targets an aggressive pancreatic cancer
subtype
A. Biederstädt, Z. Hassan, C. Schneeweis, M. Schick, L. Schneider, A. Muckenhuber, Y. Hong, G. Siegers, Lisa M Nilsson, M. Wirth, Z. Dantes, K. Steiger, K. Schunck, S. Langston, H. P. Lenhof, A. Coluccio, F. Orben, J. Slawska, A. Scherger, D. Saur, S. Müller, R. Rad, W. Weichert, Jonas A Nilsson, M. Reichert, G. Schneider, U. Keller
Gut - 2020 -
Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse
models
Lars Ny, Larissa Rizzo, Valerio Belgrano, Jón Karlsson, Henrik Jespersen, Louise Carstam, Roger Olofsson Bagge, Lisa M Nilsson, Jonas A Nilsson
Annals of Oncology - 2020 -
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout
Mice
Elin Forsberg, Mattias F Lindberg, Henrik Jespersen, Samuel Alsén, Roger Olofsson Bagge, M. Donia, I. M. Svane, Ola Nilsson, Lars Ny, Lisa M Nilsson, Jonas A Nilsson
Cancer Research - 2019 -
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label
study.
Henrik Jespersen, Roger Olofsson Bagge, Gustav Ullenhag, Ana Carneiro, Hildur Helgadottir, Ingrid Ljuslinder, Max Levin, Charlotta All-Eriksson, Bengt Andersson, Ulrika Stierner, Lisa M Nilsson, Jonas A Nilsson, Lars Ny
BMC cancer - 2019 -
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic
melanoma
Berglind Osk Einarsdottir, Joakim Karlsson, Elin Söderberg, Mattias F Lindberg, Elisa Funck-Brentano, Henrik Jespersen, Siggeir Fannar Brynjólfsson, Roger Olofsson Bagge, Louise Carstam, M. Scobie, T. Koolmeister, O. Wallner, Ulrika Stierner, U. W. Berglund, Lars Ny, Lisa M Nilsson, Erik Larsson, T. Helleday, Jonas A Nilsson
Cell Death & Disease - 2018 -
BET bromodomain inhibitors synergize with ATR inhibitors in melanoma in
melanoma.
Somsundar Veppil Muralidharan, Berglind Osk Einarsdottir, Joydeep Bhadury, Mattias F Lindberg, Jin Wu, Eric Campeau, Roger Olofsson Bagge, Ulrika Stierner, Lars Ny, Lisa M Nilsson, Jonas A Nilsson
Cell Death & Disease - 2017 -
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse
model.
Henrik Jespersen, Mattias F Lindberg, Marco Donia, Elin Söderberg, Rikke Andersen, Ulrich Keller, Lars Ny, Inge Marie Svane, Lisa M Nilsson, Jonas A Nilsson
Nature communications - 2017 -
Cancer Differentiating Agent Hexamethylene Bisacetamide Inhibits BET Bromodomain
Proteins
Lisa M Nilsson, Lydia C. Green, Somsundar Veppil Muralidharan, Dagsu Demir, M. Welin, Joydeep Bhadury, D. T. Logan, B. Walse, Jonas A Nilsson
Cancer Research - 2016 -
RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in
cancer
Taral R Lunavat, Su Chul Jang, Lisa M Nilsson, Hyun Taek Park, Gabriela Repiska, Cecilia Lässer, Jonas A Nilsson, Yong Song Gho, Jan Lötvall
Biomaterials - 2016 -
BET bromodomain inhibitors synergize with ATR inhibitors to induce DNA damage, apoptosis, senescence-associated secretory pathway and ER stress in Myc-induced lymphoma
cells.
Somsundar Veppil Muralidharan, Joydeep Bhadury, Lisa M Nilsson, Lydia C. Green, K G McLure, Jonas A Nilsson
Oncogene - 2016 -
DNA Damage Primes the Type I Interferon System via the Cytosolic DNA Sensor STING to Promote Anti-Microbial Innate
Immunity.
Anetta Härtlova, Saskia F Erttmann, Faizal Am Raffi, Anja M Schmalz, Ulrike Resch, Sharath Anugula, Stefan Lienenklaus, Lisa M Nilsson, Andrea Kröger, Jonas A Nilsson, Torben Ek, Siegfried Weiss, Nelson O Gekara
Immunity - 2015 -
Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment
decisions.
Berglind Osk Einarsdottir, Roger Olofsson Bagge, Joydeep Bhadury, Henrik Jespersen, Jan Mattsson, Lisa M Nilsson, Katarina Truvé, Marcela Davila Lopez, Peter Naredi, Ola Nilsson, Ulrika Stierner, Lars Ny, Jonas A Nilsson
Oncotarget - 2014 -
Myc-induced SUMOylation is a therapeutic vulnerability for B-cell
lymphoma.
Alexander Hoellein, Mohammad Fallahi, Stephanie Schoeffmann, Sabine Steidle, Franz X Schaub, Martina Rudelius, Iina Laitinen, Lisa M Nilsson, Andrei Goga, Christian Peschel, Jonas A Nilsson, John L Cleveland, Ulrich Keller
Blood - 2014 -
BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine
lymphoma
Joydeep Bhadury, Lisa M Nilsson, Somsundar Veppil Muralidharan, L. C. Green, Z. L. Li, E. M. Gesner, H. C. Hansen, U. B. Keller, K. G. McLure, Jonas A Nilsson
Proceedings of the National Academy of Sciences of the United States of America - 2014 -
Identification of tumorigenic and therapeutically actionable mutations in transplantable mouse tumor cells by exome
sequencing.
Joydeep Bhadury, Marcela Davila Lopez, Somsundar Veppil Muralidharan, Lisa M Nilsson, Jonas A Nilsson
Oncogenesis - 2013 -
Mouse genetics suggests cell-context dependency for Myc-regulated metabolic enzymes during
tumorigenesis.
Lisa M Nilsson, Tacha Zi Plym Forshell, Sara Rimpi, Christiane Kreutzer, Walter Pretsch, Georg W Bornkamm, Jonas A Nilsson
PLoS genetics - 2012 -
Therapeutic implications for the induced levels of Chk1 in Myc-expressing cancer
cells.
Andreas Höglund, Lisa M Nilsson, Somsundar Veppil Muralidharan, Lisa A Hasvold, Philip Merta, Martina Rudelius, Viktoriya Nikolova, Ulrich Keller, Jonas A Nilsson
Clinical cancer research : an official journal of the American Association for Cancer Research - 2011